Cycle characterisation and clinical complications in patients with cyclic Cushing's syndrome: insights from an international retrospective cohort study


Por: Nowak, E, Zhang, QL, Zhang, S, Zhao, Y, Ye, HY, Machado, MC, Moises, CCS, Toth, M, Stark, J, Yuen, KC, Gurnell, M, Macfarlane, J, Mccormack, A, Govinna, M, Gilis-Januszewska, A, Minasyan, M, Bonaventura, I, Czepielewski, MA, Ferriere, A, Gadelha, M, Isidori, AM, Kastelan, D, Maiter, D, Tabarin, A, Alexandraki, K, Chang, JL, Frontera, ED, Hanzu, FA, Matikainen, N, Miljic, D, Pichler, R, Popovic, V, Spencer-Segal, JL, Tordjman, K, Akirov, A, Araujo-Castro, M, Arvat, E, Bancos, I, Bioletto, F, Burman, P, Castinetti, F, Detomas, M, Fassnacht, M, Feelders, RA, Fountas, A, Igaz, P, Ilic, S, Isand, K, Kaltsas, G, Meyer, G, Parasiliti-Caprino, M, Newell-Price, J, Ragnarsson, O, Valassi, E, Vila, G, Wass, J, Yoel, U, Fleseriu, M and Reincke, M

Publicada: 1 dic 2025 Ahead of Print: 1 nov 2025
Resumen:
Background Cyclic Cushing's syndrome (cCS) features fluctuating cortisol secretion, often causing diagnostic errors or delays, and possibly poorer outcomes. We aimed to identify unpublished cCS cases to characterise clinical challenges and guide strategies for improving outcomes by characterising cycle patterns, peak frequency, and evaluating complications. Methods This was a retrospective observational study at 43 endocrine centres in 21 countries, including patients with confirmed Cushing's syndrome showing two or more hypercortisolaemic peaks and one or more spontaneous eucortisolaemic or hypocortisolaemic trough. Data included both clinical (eg, comorbidities and physical signs of cortisol excess) and biochemical (eg, screening and confirmatory tests) parameters, imaging, treatment, complications, and outcomes. Findings Between Dec 1, 2023 and Feb 2, 2025, 116 potentially eligible patients were identified and 110 were included. Most patients were female (84 [76%] of 110 patients), with a median age at diagnosis of 440 years (IQR 318-583). cCS origin was pituitary in 70 (64%), ectopic in 25 (23%), adrenal in three (3%), and occult in 12 (11%). Cyclicity was primarily determined by 24 h urinary free cortisol, with median peaks of 740 x ULN (range 044-299) and troughs of 031xULN (002-098). The median peak count was 30 (IQR 20-40), mostly (55 [86%] of 64 patients) occurring at irregular intervals, and was most frequent and pronounced in ectopic cCS. Symptoms worsened in 87 (81%) of 108 patients during peaks and improved in 79 (74%) of 107 patients during troughs; 31 (28%) of 110 patients had spontaneous adrenal insufficiency. Bilateral inferior petrosal sinus sampling (BIPSS) was performed during troughs in 14 patients (18% of the 78 procedures done). Imaging missed tumours in 35 (32%) of the 110 patients, and nine (8%) underwent unwarranted surgeries at the wrong anatomical site due to misclassification. After 58 years (IQR 26-105) median follow-up, 55 (50%) of 110 patients had complete biochemical surgical remission, seven (6%) had spontaneous remission, 22 (20%) were medically controlled, six (5%) had partial remission, 11 (10%) remained uncontrolled, nine (8%) were lost to follow-up. During the entire observation period, 3% (3/110) died. Delayed diagnosis (45 [41%] of 110 patients) and therapy (47 [43%]) were also observed. Interpretation Even in specialised centres, cCS diagnosis and management remain challenging with high rates of spontaneous adrenal insufficiency, inappropriate surgeries, and poor outcomes. Ectopic cCS showed the most frequent and severe peaks. These findings might help to guide imaging localisations or the timing of BIPSS in patients with active occult ACTH-dependent cCS. Hypercortisolism needs to be biochemically confirmed before BIPSS to enable correct tumour localisation. Patients with suspected or proven cCS should be equipped with salivary cortisol collection kits to capture dynamic changes as well as being prescribed glucocorticoids to be used as a precaution. Copyright (c) 2025 Elsevier Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies.

Filiaciones:
Nowak, E:
 Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Dept Med 4, D-80336 Munich, Germany

Zhang, QL:
 Fudan Univ, Huashan Hosp, Natl Ctr Neurol Disorders, Dept Neurosurg,Shanghai Med Coll, Shanghai, Peoples R China

Zhang, S:
 Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Endocrinol & Metab, Shanghai, Peoples R China

Zhao, Y:
 Fudan Univ, Huashan Hosp, Natl Ctr Neurol Disorders, Dept Neurosurg,Shanghai Med Coll, Shanghai, Peoples R China

Ye, HY:
 Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Endocrinol & Metab, Shanghai, Peoples R China

Machado, MC:
 Univ Sao Paulo, Med Sch, Div Endocrinol & Metab, Neuroendocrine Unit, Sao Paulo, Brazil

Moises, CCS:
 Univ Sao Paulo, Med Sch, Div Endocrinol & Metab, Neuroendocrine Unit, Sao Paulo, Brazil

Toth, M:
 Semmelweis Univ, Fac Med, ENETS Ctr Excellence & ENDO ERN HCP, Dept Internal Med & Oncol, Budapest, Hungary

Stark, J:
 Semmelweis Univ, Fac Med, ENETS Ctr Excellence & ENDO ERN HCP, Dept Internal Med & Oncol, Budapest, Hungary

Yuen, KC:
 Univ Arizona, Barrow Neurol Inst, Dept Neuroendocrinol & Neurosurg, Barrow Pituitary Ctr,Coll Med, Phoenix, AZ USA

 Creighton Univ, Sch Med, Phoenix, AZ USA

Gurnell, M:
 Univ Cambridge, Cambridge Endocrine Mol Imaging Grp, Inst Metab Sci, Cambridge, England

 Cambridge Univ Hosp NHS Fdn Trust, NIHR Cambridge Biomed Res Ctr, Cambridge, England

Macfarlane, J:
 Univ Cambridge, Cambridge Endocrine Mol Imaging Grp, Inst Metab Sci, Cambridge, England

 Cambridge Univ Hosp NHS Fdn Trust, NIHR Cambridge Biomed Res Ctr, Cambridge, England

Mccormack, A:
 Univ New South Wales, St Vincents Hosp, Sch Clin Med, Sydney, NSW, Australia

Govinna, M:
 Univ New South Wales, St Vincents Hosp, Sch Clin Med, Sydney, NSW, Australia

Gilis-Januszewska, A:
 Jagiellonian Univ, Med Coll, Dept Endocrinol, Krakow, Poland

Minasyan, M:
 Jagiellonian Univ, Med Coll, Dept Endocrinol, Krakow, Poland

Bonaventura, I:
 Sapienza Univ Rome, Dept Expt Med, Rome, Italy

Czepielewski, MA:
 Hosp Clin Porto Alegre, Div Endocrinol, Porto Alegre, Brazil

 Univ Fed Rio Grande do Sul, Fac Med, Programa Posgrad Endocrinol, Porto Alegre, Brazil

Ferriere, A:
 Univ Hosp Bordeaux, Dept Endocrinol Diabet & Nutr, Pessac, France

Gadelha, M:
 Inst Estadual Cerebro Paulo Niemeyer, Neuroendocrinol Div, Rio De Janeiro, Brazil

Isidori, AM:
 Sapienza Univ Rome, Dept Expt Med, Rome, Italy

Kastelan, D:
 Univ Hosp Ctr Zagreb, Dept Endocrinol, Zagreb, Croatia

 Univ Zagreb, Sch Med, Zagreb, Croatia

Maiter, D:
 UCLouvain, Dept Endocrinol, Clin Univ St Luc, Brussels, Belgium

Tabarin, A:
 Univ Hosp Bordeaux, Dept Endocrinol Diabet & Nutr, Pessac, France

Alexandraki, K:
 Natl & Kapodistrian Univ Athens, Aretaieio Hosp, Dept Surg 2, Athens, Greece

Chang, JL:
 Stanford Univ, Sch Med, Dept Med, Div Endocrinol Gerontol & Metab, Stanford, CA USA

Frontera, ED:
 Univ Michigan, Med Sch, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI USA

Hanzu, FA:
 Univ Barcelona, Endocrinol & Nutr Dept, Barcelona, Spain

 Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed Pi & Sunyer Barcelona, Barcelona, Spain

Matikainen, N:
 Helsinki Univ Hosp, Abdominal Ctr, Endocrinol, Helsinki, Finland

 Univ Helsinki, Helsinki, Finland

 Helsinki Univ Hosp, European Reference Network Rare Endocrine Condit, Helsinki, Finland

Miljic, D:
 Univ Clin Ctr Serbia, Clin Endocrinol Diabet & Metab Dis, Belgrade, Serbia

 Univ Belgrade, Fac Med, Belgrade, Serbia

Pichler, R:
 Kepler Univ Hosp, Inst Nucl Med, Neuromed Campus, Linz, Austria

Popovic, V:
 Univ Clin Ctr Serbia, Clin Endocrinol Diabet & Metab Dis, Belgrade, Serbia

 Univ Belgrade, Fac Med, Belgrade, Serbia

Spencer-Segal, JL:
 Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI USA

 Univ Michigan, Michigan Neurosci Inst, Ann Arbor, MI USA

Tordjman, K:
 Tel Aviv Univ, Inst Endocrinol Metab & Hypertens, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel

 Tel Aviv Univ, Fac Med & Hlth Sci, Tel Aviv, Israel

Akirov, A:
 Tel Aviv Univ, Fac Med, Tel Aviv, Israel

 Rabin Med Ctr, Endocrine Inst, Petah Tiqwa, Israel

Araujo-Castro, M:
 Hosp Univ Ramon & Cajal, Dept Endocrinol & Nutr, Inst Invest Ramon & Cajal, Madrid, Spain

 Univ Alcala, Madrid, Spain

Arvat, E:
 Univ Turin, Dept Med Sci, Turin, Italy

Bancos, I:
 Mayo Clin, Div Endocrinol Diabet & Nutr, Rochester, MN USA

Bioletto, F:
 Univ Turin, Dept Med Sci, Turin, Italy

Burman, P:
 Lund Univ, Skane Univ Hosp, Dept Endocrinol, Malmo, Sweden

Castinetti, F:
 Aix Marseille Univ, AP HM, Marseille Rare Dis Inst, Inserm,Marseille Med Genet, Marseille, France

 La Conception Univ Hosp, AP HM, Dept Endocrinol, CRMR HYPO, Marseille, France

Detomas, M:
 Univ Wurzburg, Univ Hosp, Dept Internal Med 1, Div Endocrinol & Diabet, Wurzburg, Germany

Fassnacht, M:
 Univ Wurzburg, Univ Hosp, Dept Internal Med 1, Div Endocrinol & Diabet, Wurzburg, Germany

Feelders, RA:
 Erasmus MC, Dept Internal Med, Div Endocrinol, Rotterdam, Netherlands

 NYU Langone Med Ctr, Dept Med, Holman Div Endocrinol Diabet & Metab, New York, NY USA

Fountas, A:
 G Gennimatas Gen Hosp Athens, Dept Endocrinol, Athens, Greece

 G Gennimatas Gen Hosp Athens, Diabet Ctr, Athens, Greece

Igaz, P:
 Semmelweis Univ, Dept Endocrinol, Budapest, Hungary

 Semmelweis Univ, Fac Med, Dept Internal Med & Oncol, Budapest, Hungary

Ilic, S:
 Univ Clin Ctr Serbia, Clin Endocrinol Diabet & Metab Dis, Belgrade, Serbia

 Univ Belgrade, Fac Med, Belgrade, Serbia

Isand, K:
 North Estonia Med Ctr, Dept Endocrinol, Tallinn, Estonia

Kaltsas, G:
 Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Dept Propaedeut Internal Med 1, Neuroendocrine Tumor Unit, Athens, Greece

Meyer, G:
 Goethe Univ Frankfurt, Univ Hosp, Dept Endocrinol, Med Clin 1, Frankfurt, Germany

Parasiliti-Caprino, M:
 Univ Turin, Dept Med Sci, Turin, Italy

Newell-Price, J:
 Univ Sheffield, Sch Med & Populat Heath, Sheffield, England

Ragnarsson, O:
 Sahlgrens Univ Hosp, Dept Endocrinol, Gothenburg, Sweden

 Univ Gothenburg, Dept Internal Med & Clin Nutr, Gothenburg, Sweden

 Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden

:
 Germans Trias i Pujol Hosp, Endocrinol Dept, Barcelona, Spain

 CIBERER, Res Inst, Unit747, Barcelona, Spain

 Univ Int Catalunya UIC, Barcelona, Spain

Vila, G:
 Med Univ Vienna, Dept Med 3, Clin Div Endocrinol & Metab, Vienna, Austria

Wass, J:
 Univ Oxford, Churchill Hosp, Dept Endocrinol, Oxford, England

Yoel, U:
 Ben Gurion Univ Negev, Soroka Univ, Med Ctr, Beer Sheva, Israel

Fleseriu, M:
 Oregon Hlth & Sci Univ, Pituitary Ctr, Dept Med, Portland, OR USA

 Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR USA

Reincke, M:
 Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Dept Med 4, D-80336 Munich, Germany

Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel
ISSN: 22138587





LANCET DIABETES & ENDOCRINOLOGY
Editorial
The Lancet Publishing Group, STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA, Países Bajos
Tipo de documento: Article
Volumen: 13 Número: 12
Páginas: 1030-1040
WOS Id: 001621336000009
ID de PubMed: 41235993
imagen Green Submitted, Green Published

MÉTRICAS